Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07431008 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

Study acronym: Cellgram-ED
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This phase II clinical trial with safety follow-up is designed to evaluate the efficacy and safety of Cellgram-ED (autologous bone marrow-derived mesenchymal stem cells) administered via intracavernous injection in patients with erectile dysfunction after radical prostatectomy.
Trial Details
NCT Number NCT07431008
Lead Sponsor Pharmicell Co., Ltd.
Conditions
(from sponsor)		 Erectile Dysfunction
Related terms Erectile Dysfunction
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov